Breaking News: Bayer Discontinues Sales of Birth Control Device Essure

By the end of 2018, Bayer HealthCare will stop selling Essure—a contraceptive device that has caused severe injuries and complications for thousands of women. Marketed as a permanent, nonsurgical method of contraception, Essure has caused debilitating adverse side-effects including chronic pain, pregnancy, miscarriage, perforation of the uterus or other organs, and even death. From 2002, when Essure was approved by the FDA, to the end of 2017, the agency had received at least 27,000 reports of adverse events relating to Essure.

In April 2018, the FDA restricted Bayer’s sales of Essure to health care providers that agreed to fully inform and review the device’s risks with patients. Two years prior, the safety regulator issued a “black box” warning on the product, the most stringent caution, outlining serious injuries that could result from using the device.

Cases on behalf of thousands of women have been filed against Bayer, claiming the manufacturer did not warn patients of Essure’s potential severe complications. Grant & Eisenhofer is Co-Liaison Counsel and serves on the Plaintiffs’ Executive Committee leading the litigation. If you have experienced complications from an Essure implant, please call us at 888-985-7228 to speak confidentially with an attorney about your potential claim.

Real Time Analytics